Elevated Mutational Age in Blood of Children Treated for Cancer Contributes to Therapy-Related Myeloid Neoplasms

Childhood cancer survivors are confronted with various chronic health conditions like therapy-related malignancies. However, it is unclear how exposure to chemotherapy contributes to the mutation burden and clonal composition of healthy tissues early in life. Here, we studied mutation accumulation i...

Descripción completa

Detalles Bibliográficos
Autores principales: Bertrums, Eline J.M., Rosendahl Huber, Axel K.M., de Kanter, Jurrian K., Brandsma, Arianne M., van Leeuwen, Anaïs J.C.N., Verheul, Mark, van den Heuvel-Eibrink, Marry M., Oka, Rurika, van Roosmalen, Markus J., de Groot-Kruseman, Hester A., Zwaan, C. Michel, Goemans, Bianca F., van Boxtel, Ruben
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2022
Materias:
Research Briefs
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7613255/
https://www.ncbi.nlm.nih.gov/pubmed/35678530
http://dx.doi.org/10.1158/2159-8290.CD-22-0120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7613255/
https://www.ncbi.nlm.nih.gov/pubmed/35678530
http://dx.doi.org/10.1158/2159-8290.CD-22-0120

Ejemplares similares